93 related articles for article (PubMed ID: 9352356)
21. Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases.
Conway JG; Andrews RC; Beaudet B; Bickett DM; Boncek V; Brodie TA; Clark RL; Crumrine RC; Leenitzer MA; McDougald DL; Han B; Hedeen K; Lin P; Milla M; Moss M; Pink H; Rabinowitz MH; Tippin T; Scates PW; Selph J; Stimpson SA; Warner J; Becherer JD
J Pharmacol Exp Ther; 2001 Sep; 298(3):900-8. PubMed ID: 11504783
[TBL] [Abstract][Full Text] [Related]
22. Regulation of peripheral inflammation by spinal p38 MAP kinase in rats.
Boyle DL; Jones TL; Hammaker D; Svensson CI; Rosengren S; Albani S; Sorkin L; Firestein GS
PLoS Med; 2006 Sep; 3(9):e338. PubMed ID: 16953659
[TBL] [Abstract][Full Text] [Related]
23. Cucurbitacin R reduces the inflammation and bone damage associated with adjuvant arthritis in lewis rats by suppression of tumor necrosis factor-alpha in T lymphocytes and macrophages.
Escandell JM; Recio MC; Máñez S; Giner RM; Cerdá-Nicolás M; Ríos JL
J Pharmacol Exp Ther; 2007 Feb; 320(2):581-90. PubMed ID: 17065367
[TBL] [Abstract][Full Text] [Related]
24. Biological activity of a small molecule indole analog, 1-[(1H-indol-3-yl)methylene]-2-phenylhydrazine (HMPH), in chronic inflammation.
Misra CS; Gejjalagere Honnappa C; Jitta SR; Gourishetti K; Daram P; Singh MP; Hosur Shrungeswara A; Nayak Y; Unnikrishnan MK
Chem Biol Interact; 2016 Jan; 244():71-83. PubMed ID: 26549477
[TBL] [Abstract][Full Text] [Related]
25. Trikatu, an herbal compound as immunomodulatory and anti-inflammatory agent in the treatment of rheumatoid arthritis--an experimental study.
Murunikkara V; Rasool M
Cell Immunol; 2014 Jan; 287(1):62-8. PubMed ID: 24394943
[TBL] [Abstract][Full Text] [Related]
26. Anti-inflammatory and cartilage-protecting effects of an intra-articularly injected anti-TNF{alpha} single-chain Fv antibody (ESBA105) designed for local therapeutic use.
Urech DM; Feige U; Ewert S; Schlosser V; Ottiger M; Polzer K; Schett G; Lichtlen P
Ann Rheum Dis; 2010 Feb; 69(2):443-9. PubMed ID: 19293161
[TBL] [Abstract][Full Text] [Related]
27. Effects and mechanisms of glucosides of chaenomeles speciosa on collagen-induced arthritis in rats.
Chen Q; Wei W
Int Immunopharmacol; 2003 Apr; 3(4):593-608. PubMed ID: 12689663
[TBL] [Abstract][Full Text] [Related]
28. Comparison of anti-arthritic properties of leflunomide with methotrexate and FK506: effect on T cell activation-induced inflammatory cytokine production in vitro and rat adjuvant-induced arthritis.
Magari K; Miyata S; Nishigaki F; Ohkubo Y; Mutoh S
Inflamm Res; 2004 Oct; 53(10):544-50. PubMed ID: 15597149
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis.
Silveira KD; Coelho FM; Vieira AT; Barroso LC; Queiroz-Junior CM; Costa VV; Sousa LF; Oliveira ML; Bader M; Silva TA; Santos RA; Silva AC; Teixeira MM
Peptides; 2013 Aug; 46():53-63. PubMed ID: 23727291
[TBL] [Abstract][Full Text] [Related]
30. Effect of FR133605, a novel cytokine suppressive agent, on bone and cartilage destruction in adjuvant arthritic rats.
Yamamoto N; Sakai F; Yamazaki H; Kawai Y; Nakahara K; Okuhara M
J Rheumatol; 1996 Oct; 23(10):1778-83. PubMed ID: 8895158
[TBL] [Abstract][Full Text] [Related]
31. TNF-alpha blockade by a dimeric TNF type I receptor molecule selectively inhibits adaptive immune responses.
Colagiovanni DB; Suniga MA; Frazier JL; Edwards CK; Fleshner M; McCay JA; White KL; Shopp GM
Immunopharmacol Immunotoxicol; 2000 Nov; 22(4):627-51. PubMed ID: 11105778
[TBL] [Abstract][Full Text] [Related]
32. Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation.
Hope HR; Anderson GD; Burnette BL; Compton RP; Devraj RV; Hirsch JL; Keith RH; Li X; Mbalaviele G; Messing DM; Saabye MJ; Schindler JF; Selness SR; Stillwell LI; Webb EG; Zhang J; Monahan JB
J Pharmacol Exp Ther; 2009 Dec; 331(3):882-95. PubMed ID: 19720877
[TBL] [Abstract][Full Text] [Related]
33. Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines.
Finnegan A; Mikecz K; Tao P; Glant TT
J Immunol; 1999 Nov; 163(10):5383-90. PubMed ID: 10553063
[TBL] [Abstract][Full Text] [Related]
34. A selective novel low-molecular-weight inhibitor of IkappaB kinase-beta (IKK-beta) prevents pulmonary inflammation and shows broad anti-inflammatory activity.
Ziegelbauer K; Gantner F; Lukacs NW; Berlin A; Fuchikami K; Niki T; Sakai K; Inbe H; Takeshita K; Ishimori M; Komura H; Murata T; Lowinger T; Bacon KB
Br J Pharmacol; 2005 May; 145(2):178-92. PubMed ID: 15753951
[TBL] [Abstract][Full Text] [Related]
35. Allyl isothiocyanate (AITC) and phenyl isothiocyanate (PITC) inhibit tumour-specific angiogenesis by downregulating nitric oxide (NO) and tumour necrosis factor-alpha (TNF-alpha) production.
Thejass P; Kuttan G
Nitric Oxide; 2007 Mar; 16(2):247-57. PubMed ID: 17097904
[TBL] [Abstract][Full Text] [Related]
36. Pyrano-isochromanones as IL-6 inhibitors: synthesis, in vitro and in vivo antiarthritic activity.
Jain SK; Singh S; Khajuria A; Guru SK; Joshi P; Meena S; Nadkarni JR; Singh A; Bharate SS; Bhushan S; Bharate SB; Vishwakarma RA
J Med Chem; 2014 Aug; 57(16):7085-97. PubMed ID: 25111439
[TBL] [Abstract][Full Text] [Related]
37. Heparin inhibits the inflammatory response induced by LPS and HMGB1 by blocking the binding of HMGB1 to the surface of macrophages.
Li L; Ling Y; Huang M; Yin T; Gou SM; Zhan NY; Xiong JX; Wu HS; Yang ZY; Wang CY
Cytokine; 2015 Mar; 72(1):36-42. PubMed ID: 25562836
[TBL] [Abstract][Full Text] [Related]
38. The selective sphingosine 1-phosphate receptor 1 agonist ponesimod protects against lymphocyte-mediated tissue inflammation.
Piali L; Froidevaux S; Hess P; Nayler O; Bolli MH; Schlosser E; Kohl C; Steiner B; Clozel M
J Pharmacol Exp Ther; 2011 May; 337(2):547-56. PubMed ID: 21345969
[TBL] [Abstract][Full Text] [Related]
39. [Effects of icariin on inflammation model stimulated by lipopolysaccharide in vitro and in vivo].
Wu JF; Dong JC; Xu CQ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Apr; 29(4):330-4. PubMed ID: 19526759
[TBL] [Abstract][Full Text] [Related]
40. 2-aminothiazole as a novel kinase inhibitor template. Structure-activity relationship studies toward the discovery of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1- piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase inhibitor.
Das J; Chen P; Norris D; Padmanabha R; Lin J; Moquin RV; Shen Z; Cook LS; Doweyko AM; Pitt S; Pang S; Shen DR; Fang Q; de Fex HF; McIntyre KW; Shuster DJ; Gillooly KM; Behnia K; Schieven GL; Wityak J; Barrish JC
J Med Chem; 2006 Nov; 49(23):6819-32. PubMed ID: 17154512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
